Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Oncology Pubmed

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.

Loading next page...
 
/lp/pubmed/axitinib-treatment-in-patients-with-cytokine-refractory-metastatic-yh9nyhaDgS

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1470-2045
DOI
10.1016/S1470-2045(07)70285-1
pmid
17959415

Abstract

Journal

The Lancet OncologyPubmed

Published: Dec 19, 2007

There are no references for this article.